Evidence map›Paper›PMID 41278166›Full record

ArticleWorld journal of gastroenterology2025

Development and validation of a predictive model for portal-systemic venous invasion grading in borderline resectable pancreatic cancer.

Fang-Fei Wang, Xiao-Di Dai, Xin Zhao, Qiang He, Shao-Cheng Lyu

Abstract readValidation Study
In one paragraph

Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fang-Fei WangDepartment of Hepatobiliary Pancreas and Spleen Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
Xiao-Di DaiDepartment of Hepatobiliary Pancreas and Spleen Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
Xin ZhaoDepartment of Hepatobiliary Pancreas and Spleen Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
Qiang HeDepartment of Hepatobiliary Pancreas and Spleen Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
Shao-Cheng LyuDepartment of Hepatobiliary Pancreas and Spleen Surgery, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China. shaocheng0502@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPortosystemic venous invasion (PSVI) depth critically influences prognosis in borderline resectable pancreatic cancer (BRPC), necessitating precise preoperative discrimination for personalized therapy.

aimTo develop and validate a preoperative nomogram integrating computed tomography parameters and carbohydrate antigen 19-9 (CA19-9) kinetics for predicting PSVI depth in treatment-naive BRPC.

methodsThis retrospective cohort study analyzed 167 BRPC patients undergoing radical resection between 2011 and 2023. Patients were stratified by pathological PSVI depth [no venous invasion (VI)/adventitial/muscularis propria/intimal]. Kaplan-Meier and ordinal logistic regression identified preoperative predictors from clinical/laboratory/computed tomography parameters (

resultsPSVI depth significantly stratified survival.: Intimal VI showed worst prognosis (median overall survival: 9 months, 5-year overall survival: 0%

conclusionThis model integrates routine indicators to preoperatively quantify PSVI depth, guiding precision treatment.

Indexed as

NomogramsPancreatic NeoplasmsPortal VeinAgedAged, 80 and overCA-19-9 AntigenFemaleHumansKaplan-Meier EstimateMaleMiddle AgedNeoplasm GradingNeoplasm InvasivenessPancreasPancreatectomyPredictive Value of TestsCA-19-9 AntigenAdventitial invasionBorderline resectable pancreatic cancerIntimal invasionMuscularis propria invasionPathological gradingPortosystemic venous invasionPredictive model

Identifiers

PMID41278166
PMCPMC12635751

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.